(Q33333615)

English

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease

scientific article

In more languages

Statements

scholarly article

1 reference

25 July 2017

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease (English)

1 reference

25 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

12

object named as

Califf RM

1 reference

25 July 2017

13

object named as

Topol EJ

1 reference

25 July 2017

Dean J Kereiakes

5

object named as

Kereiakes DJ

1 reference

25 July 2017

author name string

Harrington RA

1

1 reference

25 July 2017

Armstrong PW

2

1 reference

25 July 2017

Graffagnino C

3

1 reference

25 July 2017

Van De Werf F

4

1 reference

25 July 2017

Sigmon KN

6

1 reference

25 July 2017

Card T

7

1 reference

25 July 2017

Joseph DM

8

1 reference

25 July 2017

Samuels R

9

1 reference

25 July 2017

Granett J

10

1 reference

25 July 2017

Chan R

11

1 reference

25 July 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

25 July 2017

1 reference

25 July 2017

102

1 reference

25 July 2017

728-735

1 reference

25 July 2017

7

1 reference

25 July 2017

Identifiers

10.1161/01.CIR.102.7.728

1 reference

25 July 2017

1 reference

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33333615&oldid=1956956946"